Sign up to save your podcasts
Or
Share JAMA Oncology : Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD.
Related Content:
- Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD.
Related Content:
- Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
More shows like JAMA Network
View all
Science Magazine Podcast
804 Listeners
JAMA Editors' Summary
129 Listeners
HBR IdeaCast
226 Listeners
NEJM This Week
313 Listeners
JAMA Author Interviews
165 Listeners
JAMA Clinical Reviews
482 Listeners
AFP: American Family Physician Podcast
682 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
Frankly Speaking About Family Medicine
256 Listeners
The Curbsiders Internal Medicine Podcast
3,328 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Psychiatry Author Interviews
24 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
87 Listeners
The Indicator from Planet Money
9,539 Listeners
Annals On Call Podcast
180 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
320 Listeners
Cardionerds: A Cardiology Podcast
413 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
AMA Update
93 Listeners
NEJM AI Grand Rounds
51 Listeners